RAZZOLINI, RENATO
 Distribuzione geografica
Continente #
NA - Nord America 6.908
EU - Europa 1.167
AS - Asia 676
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
SA - Sud America 2
AF - Africa 1
Totale 8.772
Nazione #
US - Stati Uniti d'America 6.901
CN - Cina 532
FI - Finlandia 307
SE - Svezia 293
IT - Italia 175
DE - Germania 145
UA - Ucraina 136
VN - Vietnam 99
GB - Regno Unito 67
IN - India 33
IE - Irlanda 17
NL - Olanda 12
EU - Europa 11
CA - Canada 7
TR - Turchia 6
FR - Francia 5
NZ - Nuova Zelanda 5
RO - Romania 4
RU - Federazione Russa 3
SG - Singapore 3
AU - Australia 2
GR - Grecia 2
BR - Brasile 1
BY - Bielorussia 1
IR - Iran 1
JP - Giappone 1
LK - Sri Lanka 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 8.772
Città #
Chandler 947
Fairfield 942
Jacksonville 583
Woodbridge 500
Houston 434
Wilmington 434
Ashburn 399
Cambridge 328
Seattle 290
Princeton 287
Ann Arbor 246
Medford 149
Roxbury 144
San Diego 141
Nanjing 136
Beijing 131
Helsinki 107
Des Moines 103
Dong Ket 99
Boardman 89
Guangzhou 55
New York 45
Padova 37
Nanchang 36
Hebei 35
Shenyang 32
Norwalk 23
Tianjin 21
Falls Church 19
Jiaxing 19
Dublin 17
Changsha 13
Redwood City 13
London 12
Jinan 11
Milan 11
Rockville 11
Rome 11
Borås 9
Ferrara 9
Washington 9
Ogden 8
Kharkiv 7
Venezia 6
Yenibosna 6
Hefei 5
Kunming 5
Venice 5
Cagliari 4
Horia 4
Taizhou 4
Castelnuovo Rangone 3
Costa Mesa 3
Dearborn 3
Hounslow 3
Kilburn 3
Lucca 3
Mestre 3
Orange 3
San Francisco 3
Shanghai 3
Amsterdam 2
Auckland 2
Brindisi 2
Chiswick 2
Easton 2
Fuzhou 2
Groningen 2
Indiana 2
Leawood 2
Messina 2
Munich 2
Pinehaven 2
Pune 2
Sandrigo 2
Santa Clara 2
Tappahannock 2
Terni 2
Torino 2
Uta 2
Voorschoten 2
Wenzhou 2
Acton 1
Aigaleo 1
Albignasego 1
Anchorage 1
Ardabil 1
Atlanta 1
Auburn Hills 1
Augusta 1
Baltimore 1
Baotou 1
Basildon 1
Bedworth 1
Belgorod 1
Berlin 1
Buffalo 1
Casier 1
Catania 1
Chicago 1
Totale 7.081
Nome #
Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve Implantation. 116
Morphologic spectrum of primary restrictive cardiomyopathy. 96
Alström Syndrome: Cardiac Magnetic Resonance findings. 93
Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block. 92
Predictors and time-related impact of distal embolization during primary angioplasty 91
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 90
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. 87
Malattie del cuore e dei vasi 85
Influence of transmurality infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty 85
Relation of aortic valve weight to severity of aortic stenosis. 83
Endomyocardial biopsy in heterotopic heart-transplant recipients via the femoral vein 81
Simulation of chronic mitral regurgitation 81
The C-reactive protein levels in left ventricular dysfunction of different etiology. 81
The concept of preload and its evaluation in the intact left ventricle. 79
Moderate-to-severe ischemic mitral regurgitation and multivessel coronary artery disease: Impact of different treatment on survival and rehospitalization. 79
Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. 76
Risk stratification and prognostic assessment by myocardial perfusion-gated SPECT in patients with left bundle-branch block and low-intermediate cardiac risk. 76
Letter by Covolo et al regarding article, "accurate assessment of aortic stenosis: a review of diagnostic modalities and hemodynamics". 76
Interaction Among Risk-Time and Benefit of Primary Angioplasty 75
Letter by Tarantini et al Regarding Article, "Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy" 74
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 74
Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all. 72
Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: a 10-year follow-up analysis. 72
Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery 70
Age-related outcome of percutaneous mitral balloon valvuloplasty 69
Cardiac evaluation of myocardial involvement in Anderson–Fabry disease by cardiac magnetic resonance imaging: a study of five patients 69
Left ventricular size and function in double inlet left ventricle. 68
Thrombus burden and myocardial damage during primary percutaneous coronary intervention. 67
Evaluation of the chronic antianginal effect of molsidomine 67
Impact of age on immediate and late results of percutaneous mitral balloon valvuloplasty in a series of 626 patients. 66
Adjusting the benefits of primary angioplasty against thrombolytic therapy for acute myocardial infarction: the role of time 65
LV function in patients with mitral regurgitation. 65
Survival benefits of primary angioplasty over thrombolysis after adjustment for percutaneous transluminal coronary angioplasty related time delay 65
Distal coronary microembolization in acute coronary syndromes: does it really play a major role? 64
Myocardial function in heart failure. 64
Non-Cardiovascular Mortality, Low-Density Lipoprotein Cholesterol and Statins: A Meta-Regression Analysis. 64
Analytical expression of effective afterload in aortic and mitral regurgitation 63
Pressure response to vasopressors and mortality after direct angioplasty for cardiogenic shock 63
Letter by Razzolini and Tarantini regarding article, "Restrictive Left Ventricular Filling Pattern Does Not Result From Increased Left Atrial Pressure Alone" 63
A postmortem investigation of distal coronary microembolization in acute coronary syndromes 63
Acute changes in left ventricular function after percutaneous transluminal mitral valvuplasty 62
Cardiomiopatia dilatativa: cosa chiedere alla valutazione clinica e bioumorale 62
Patient risk profile and benefit from an invasive approach in the initial management of non-ST-segment elevation acute coronary syndrome 62
Initial Q Wave at Presentation of Acute Myocardial Infarction is Better Than Time to Treatment in Predicting Myocardial and Microvascular Damage in Patients with Anterior Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 62
Non-cardiovascular mortality, LDL cholesterol and statins: A metaregression analysis 61
The Time-delay that Nullify the Advantage of Primary Percutaneous Coronary Angioplasty over Fibrinolysis is Affected by Patients' Risk: 1-Hour Does Not Fit All 61
Pressure-dependence of the Aortic Valve Gradient 61
Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock 61
[Actions of contrast media. Construction of a model of hemodynamic stress by continuous multi-parameter monitoring]. 61
Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide. 60
Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction 60
Value and limitations of transesophageal echocardiographic monitoring during percutaneous balloon mitral valvotomy. 59
Predictors and time-related impact of distal embolization during primary angioplasty. 59
Valvuloplastica mitralica percutanea: risultati immediati e a lungo termine 58
Aortic Stenosis (acquired) 58
Pulmonary vascular resistance variation over time in candidates for heart transplantation 58
Periprocedural abciximab administration in ST elevation myocardial infarction patients - Effect on severe microvascular obstruction beyond the restoration of epicardial coronary flow by primary angioplasty 58
Relationship Among Primary Angioplasty Related Delay, Risk Of The Patients With St Elevation Myocardial Infarction And Survival Benefit Of Primary Angiopasty Over Fibrinolysis 57
Explanation of the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction 57
Measurement of systemic resistances in aortic regurgitation. 57
Valvuloplastica mitralica percutanea nella restesnosi mitralica dopo commissurotomia chirurgica 56
Valve replacement for severe aortic stenosis with low transvalvular gradient and left ventricular ejection fraction exceeding 0.50. 55
[Natural history of dilated cardiomyopathy]. 55
Haemodynamic effects of nisoldipine by oral route. 55
Understanding and recognition of the right ventricular function and dysfunction via a numerical study 55
Impact of Aortic Valve Replacement on Survival of Patients With Severe Aortic Stenosis With Low Transvalvular Gradient and Preserved Left Ventricular Ejection Fraction 54
Aortic stenosis severity assessment: how to match non-invasive to invasive metrics. 54
Short-lasting hemodynamic and clinical benefits from percutaneous balloon valvuloplasty for calcific aortic stenosis. 53
Severe ischemic left ventricular failure: coronary operation or heart transplantation? 51
EFFETTI DEL CARVEDILOLO SULL'ACCOPPIAMENTO VENTRICOLO-ARTERIOSO NELLO SCOMPENSO CARDIACO 50
Outcome of 290 patients with aortic dissection. A 12-year multicentre experience. 50
Disfunzione diastolica e scompenso cardiaco: una realtà clinica? 49
Relation of patient age to outcome of percutaneous mitral valvuloplasty 49
Myocardial structural correlates of late persistence of ST-segment elevation in the subacute stage of myocardial infarction 48
Ischemic cardiomyopathy: lack of clinical applicability of the WHO/ISFC classification of cardiomyopathies 48
Risultati immediati e a distanza del trattamento di lesioni focali di bypass venosi aortocoronarici mediante l'impianto di stent 47
Aterectomia totazionale e PTCA in lesioni coronariche complesse (B2 e C2): risultati immediati e a distanza 46
Impact of angiographic assessment of myocardial reperfusion on outcome after primary angioplasty in patients with cardiogenic shock 46
[Clinical and angiographic observations in aneurysm of the membranous septum. Pathologenetic implications]. 46
Re-valvuloplastica mitralica percutanea: osservazioni sulla nostra casistica 45
Impact of myocardial blush grade on left ventricular remodeling after direct percutaneous coronary intervention for acute myocardial infarction 45
Pulmonary atresia with intact ventricular septum: a quantitative cineventriculographic study of the right and left ventricular function. 45
Come stratificare e come ridurre il rischio chirurgico-anestesiologico in chirurgia vascolare. 44
Survival and rehospitalization in patients with severe ischemic mitral regurgitation and multivessel coronary artery disease undergoing different treatment 44
[Cineventriculographic analysis of the curvature of the left ventricular margin and its significance in the diagnosis of contraction disorders]. 44
Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance 43
Discrepancies between catheter and Doppler estimates of aortic stenosis: The role of pressure recovery evaluated 'in vivo' 43
[Complications of retrograde arterial catheterization using the percutaneous femoral route. Observations on 4,686 cases]. 43
[Coriolis acceleration. Vestibulo-vegetative stimulations with regard to the motion sickness of astronauts. Experimental researches]. 43
Towards defining the role of drug eluting stents. 43
Duration of ischemia is a major determinant of transmurality and microvascular obstruction assessed by magnetic resonance after primary angioplasty 42
[Changes of the amplitude of the R wave and behavior of the ST tract during exercise test. Comparison with hemodynamic and coronarographic data]. 41
[Congenital diverticulum of the left ventricle]. 41
[Antihypertensive effects of clonidine and of the clonidine-chlorthalidone combination]. 41
[Coronary arteriography. Review of 1000 consecutive personal cases]. 41
Quando è critica una stenosi valvolare? 40
[Isolated mitral stenosis: systolic and diastolic dynamic geometry of the left ventricle. Integration with several hemodynamic parametres (author's transl)]. 40
[Complete transposition of the great arteries: hypertensiol pulmonary vascular disease in the first six months of life (author's transl)]. 40
Ventricular development and function in complete transposition: angiocardiographic evaluation. 40
Percutaneous mitral balloon valvuloplasty after surgical commissurotomy: a comparative study 39
Totale 6.077
Categoria #
all - tutte 32.223
article - articoli 31.173
book - libri 158
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 459
Totale 64.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019502 0 0 0 0 0 0 0 0 0 126 207 169
2019/20201.684 373 35 18 101 167 142 117 200 130 176 140 85
2020/20211.178 38 88 21 108 41 115 38 113 165 73 184 194
2021/20222.072 27 380 105 256 50 173 54 244 75 20 138 550
2022/20231.842 431 202 29 238 318 209 2 106 201 7 64 35
2023/2024507 35 114 71 50 68 81 19 48 12 9 0 0
Totale 8.802